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1.
Annex
QUESTIONNAIRE ON THE CAPABILITIES OF MEMBER 
STATES REGARDING THE ANALYSIS OF BIOMEDICAL 
SAMPLES
1. State Party USA
Lawrence Livermore National Laboratory2. Laboratory name
3. Contact person Family name:
Alcaraz
First name:
Armando
Street: East Ave, L-178
Number: 7000 Post code: 94550
City: Livermore
4. Contact address
(Please do not give a 
post-office box number)
Country: USA
5. E-mail address
Work: 001.925.423.68896. Telephone numbers, 
including country and city 
codes
Mobile: 001.925.784.6169
Home:7. Fax numbers, including 
country and city codes Work: 001.925.423.9014
Yes X No 8. Is your laboratory currently conducting 
research into techniques for analysing 
biomedical samples for the presence of 
scheduled chemicals, their free metabolites, or 
other conjugated biomarkers of exposure, 
such as DNA or protein adducts?
If so, please provide a separate list 
of references to any publications by 
your laboratory in this area and, if 
possible, copies of any of these 
publications that have appeared 
within the last five years.
We are currently participating in “unofficial” Round 
Robins with other US labs to establish quality-control 
systems, analytical methods and reporting criteria.
9. If your laboratory is active 
in biomedical sampling and 
analysis, please describe 
the quality-control systems 
it has in place, such as 
external accreditation, and 
recognition for Good 
Laboratory Practice.
Yes X No 
Please provide any comments in the space below.
LLNL would be interested in participating with 
OPCW and Member States to establish new 
capabilities in the analysis of biomedical samples.
10. Is your laboratory 
interested in participating 
in an effort to establish an
OPCW capability to 
analyse biomedical 
samples?
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1.
Yes: X No 
Please provide any comments in the space below.
LLNL is currently an OPCW Designated laboratory 
and has participated in OPCW proficiency testing 
since 2001.
11. Is your laboratory willing 
to be designated by the 
Director-General of the 
Secretariat to analyse 
biomedical samples in the 
context of OPCW activities 
and proficiency testing?
Yes X No 
Please provide any comments in the space below.
Our participation in inter-laboratory exercises would 
depend on funding allocations and may vary.
12. Is your laboratory willing 
to participate in inter-
laboratory confidence-
building exercises?
Yes:X No 
Please provide any comments in the space below.
LLNL is currently an OPCW Designated laboratory 
and would like to extend its scope to the analysis 
biomedical samples.
13. Is your laboratory willing 
to participate in proficiency 
testing with a view to being 
selected as an OPCW 
Designated Laboratory?
Yes: X No 
Please provide any comments in the space below.
Yes, if funding were made available.
14. Is your laboratory willing 
to share its knowledge and 
skills regarding the analysis 
of biomedical samples-for 
example, by providing 
training to technicians from 
other Member States?
Yes: X No 
Please provide any comments in the space below.
Yes, if funding were made available.
15. Would your laboratory be 
willing to analyse samples 
obtained by the OPCW in 
connection with an 
investigation into the 
alleged use of chemical 
weapons?
S/545/2006
A
nnex
A
ppendix 1
page 3
Appendix 1
SAMPLING AND ANALYSIS OF BIOMEDICAL SAMPLES
FOR THE PRESENCE OF CHEMICAL AGENTS: KEY METHODS1
The following tables list analytical methods that the temporary working group on biomedical samples considers to be particularly useful.  Please 
indicate, in the fourth column, what capability, if any, your laboratory has for each method listed.  Please make any additional comments in the 
last column.
TABLE 1: ANALYTICAL METHODS TO CHECK FOR THE PRESENCE OF SULFUR MUSTARD
Is the Method 
Available in 
Your 
Laboratory?
Sample 
Type
Key Biomarkers Analytical Methods
Currently Available
Yes No
Comments
Urine Thiodiglycol 
(TDG)
GC-MS-MS X Currently not ISO-17025 validated and detection 
limits have not been optimized
TDGO β-lyase 
metabolites
LC-MS-MS X Currently not ISO-17025 validated and detection 
limits have not been optimized
Blood Protein adducts: Chemical or enzymatic 
digestion, followed by:
No If provided with a literature reference or OPCW 
protocol we could conduct the analysis 
N-terminal valine 
on Hb
GC-MS or GC-MS-MS No If provided with a literature reference or OPCW 
protocol we could conduct the analysis
Blood, 
continued
Protein adducts: Chemical or enzymatic 
digestion, followed by:
  
1 Adapted from Appendix 6 to the report of the Seventh Session of the SAB (SAB-7/1).
Legend for abbreviations used in this Annex:
BA: Benzilic acid DNA: Deoxyribose nucleic acid Hb: Haemoglobin Q: 3-quinuclidinol
BuChE: Butyryl-
cholinesterase
EI: Electron impact HETE: Hydroxyethylthioethyl TDGO: Thiodiglycol 
oxide
BZ: 3-quinuclidinyl benzilate ELISA: Enzyme-linked immunosorbent assay HR: High resolution
CVAA: 2-chlorovinyl-
arsenous acid
GC-MS-MS: gas chromatography–mass 
spectrometry–mass spectrometry
LC-MS-MS: Liquid chromatography-
mass spectrometry-mass spectrometry
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Is the Method 
Available in 
Your 
Laboratory?
Sample 
Type
Key Biomarkers Analytical Methods
Currently Available
Yes No
Comments
If provided with a literature reference or OPCW 
protocol we could conduct the analysis
Histidine 
residues on Hb
LC-tandem MS Y
If provided with a literature reference or OPCW 
protocol we could conduct the analysis
Cysteine residue 
on albumin
LC-tandem MS Y
If provided with a literature reference or OPCW 
protocol we could conduct the analysis
Aspartic 
acid/glutamic 
acid residues on 
blood proteins 
and keratin
GC-MS Y
Urine DNA adducts:
If provided with a literature reference or OPCW 
protocol we could conduct the analysis
Alkylation of 
deoxyguanosine 
(N7)
LC-MS-MS for N7-
HETE-guanine
Y
Blood Alkylation of 
deoxyguanosine 
(N7)
ELISA for N7-HETE-
guanosine-5’-phosphate
N
Other biomarkers
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TABLE 2: ANALYTICAL METHODS TO CHECK FOR THE PRESENCE OF NERVE AGENTS
Is the Method 
Available in Your 
Laboratory?
Sample 
Type
Key Biomarkers Analytical 
Methods
Recommended
Yes No
Comments
Blood Cholinesterase 
activity
N
Blood Fluoride 
reactivation 
method: 
If provided with a literature reference or OPCW 
protocol we could conduct the analysis
Phosphylated 
BuChE (and 
other proteins)
GC-MS Y
Blood Analysis of 
phosphylated 
peptides:
Phosphylated 
BuChE
LC-MS-MS (after 
enzymatic digestion 
of modified 
cholinesterase)
Y If provided with a literature reference or OPCW 
protocol we could conduct the analysis
Urine/serum Hydrolysis 
products:
If provided with a literature reference or OPCW 
protocol we could conduct the analysis
GC-MS-MS Y
If provided with a literature reference or OPCW 
protocol we could conduct the analysis
Alkyl methyl-
phosphonic 
acids (does not 
include tabun) LC-MS-MS Y
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Is the Method 
Available in Your 
Laboratory?
Sample 
Type
Key Biomarkers Analytical 
Methods
Recommended
Yes No
Comments
If provided with a literature reference or OPCW 
protocol we could conduct the analysis
Other biomarkers Y
TABLE 3: ANALYTICAL METHODS TO CHECK FOR THE PRESENCE OF LEWISITE
Is the Method 
Available in Your 
Laboratory?
Sample 
Type
Key Biomarkers Analytical 
Methods
Recommended
Yes No
Comments
Currently not ISO-17025 validated and detection 
limits have not been optimized
Urine CVAA Solid-phase micro-
extraction 
headspace 
sampling, followed 
by GC-MS with EI
ionisation
Y
Currently not ISO-17025 validated and detection 
limits have not been optimized
Blood CVAA (globin 
bound and free)
GC-MS Y
Other biomarkers
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TABLE 4: ANALYTICAL METHODS TO CHECK FOR THE PRESENCE OF PHOSGENE
Is the Method 
Available in Your 
Laboratory?
Sample 
Type
Key Biomarkers Analytical 
Methods
Recommended
Yes No
Comments
Blood Protein adduct:
If provided with a literature reference or OPCW 
protocol we could conduct the analysis
Albumin 
peptide
LC-MS-MS Y
Other biomarkers
TABLE 5: ANALYTICAL METHODS TO CHECK FOR THE PRESENCE OF CYANIDE
Is the Method 
Available in Your 
Laboratory?
Sample 
Type
Key Biomarkers Analytical 
Methods
Recommended
Yes No
Comments
Blood Cyanide itself GC Y If provided with a literature reference or OPCW 
protocol we could conduct the analysis
Urine Cystine adduct HPLC Y If provided with a literature reference or OPCW 
protocol we could conduct the analysis
SCN GC–LC Y If provided with a literature reference or OPCW 
protocol we could conduct the analysis
2-amino-
thiazoline, 4-
carboxylic acid
GC–LC Y If provided with a literature reference or OPCW 
protocol we could conduct the analysis
Other biomarkers
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TABLE 6: ANALYTICAL METHODS TO CHECK FOR THE PRESENCE OF BZ
Is the Method 
Available in Your 
Laboratory?
Sample 
Type
Key Biomarkers Analytical 
Methods
Recommended
Yes No
Comments
Currently not ISO-17025 validated and detection 
limits have not been optimized
Urine BZ, BA
Q
LC-MS-MS Y
Other biomarkers
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Appendix 2
ANALYTICAL METHODS IN USE IN YOUR LABORATORY2
Sample Type3 Biomarker4 Analytical Technique 
and Instrumentation5
Comments6
- - - o - - -
  
2 Please include additional copies of this page if necessary.
3 Blood, urine, and so on
4 Phosphylated BuChE, CVAA, and so on
5 GC-MS, LC-MS-MS, and so on
6 Please mention any relevant quality-control procedures, any accreditation the laboratory has earned in respect of this method, and so on.
